ScholarIQanswers from OpenAlex
Lukaskrankenhaus
InstitutionResearch output, impact & collaborations
Lukaskrankenhaus is a institution indexed in ScholarIQ from OpenAlex.
What is known about Lukaskrankenhaus?
ScholarIQrecord summary
Lukaskrankenhaus is a research organisation in Neuss, DE. OpenAlex records 1,153 works and 41,794 citations for it. 296 researchers list it as their most recent affiliation.
How many works does Lukaskrankenhaus have?
ScholarIQindexed works
Lukaskrankenhaus has 1,153 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Lukaskrankenhaus have?
ScholarIQcitation count
Lukaskrankenhaus has 41,794 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Lukaskrankenhaus?
ScholarIQresearcher count
Lukaskrankenhaus has 296 researchers in the ScholarIQ index.
What is the average h-index at Lukaskrankenhaus?
ScholarIQavg h-index
Lukaskrankenhaus has an average h-index of 66 in OpenAlex.
What is the ROR of Lukaskrankenhaus?
ScholarIQror
The ROR for Lukaskrankenhaus is on the source record.
What is the OpenAlex record for Lukaskrankenhaus?
ScholarIQopenalex
The OpenAlex for Lukaskrankenhaus is on the source record.
Who are the most-cited researchers behind Lukaskrankenhaus?
ScholarIQtop researchers by citations
What are the most-cited papers on Lukaskrankenhaus?
ScholarIQmost cited works
Contemporary Presentation and Management of Valvular Heart Disease
Bernard Iung, Victoria Delgado, Raphaël Rosenhek, Susanna Price, Bernard Prendergast, Olaf Wendler, Michele De Bonis, Christophe Tribouilloy, Arturo Evangelista, Alexander Bogachev‐Prokophiev, Astrid Apor, Hüseyin Ince, Cécile Laroche, Bogdan A. Popescu, Luc Piérard, Michael Haude, Gerhard Hindricks, Frank Ruschitzka, Stefan Windecker, Jeroen J. Bax, Aldo P. Maggioni, Alec Vahanian, And the EORP VHD II Investigators, Artan Goda, Julia Mascherbauer, Fuad Samadov, Agnes Pasquet, Katerina Linhartova, Nikolaj Ihlemann, Magdy Abdelhamid, Antti Saraste, Christophe Tribouilloy, Elizabeta Srbinovska Kostovska, Gani Bajraktari, Erkin Mirrakhimov, Andrejs Erglis, Vaida Mizariene, Daniela Cassar, Victoria Delgado, Lidia Tomkiewicz-Pajak, Regina Ribeiras, Branko Beleslin, Iveta Simkova, Arturo Evangelista, Sait Mesut Dogan, Shelley Rahman-Haley
A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial
Patrick W. Serruys, Bernard Chevalier, Dariusz Dudek, Ángel Cequier, Didier Carrié, Andrés Íñiguez, Marcello Dominici, René J. van der Schaaf, Michael Haude, Luc Wasungu, Susan Veldhof, Lei Peng, Peter Stæhr, Maik J. Grundeken, Yuki Ishibashi, Héctor M. García‐García, Yoshinobu Onuma
Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial
Patrick W. Serruys, Bernard Chevalier, Yohei Sotomi, Ángel Cequier, Didier Carrié, Jan J. Piek, Ad J. van Boven, Marcello Dominici, Dariusz Dudek, Dougal McClean, Steffen Helqvist, Michael Haude, Sebastian Reith, Manuel Almeida, Gianluca Campo, Andrés Íñiguez, Manel Sabaté, Stephan Windecker, Yoshinobu Onuma
How much of the research on Lukaskrankenhaus is open access?
ScholarIQopen access share
100%OPEN ACCESS